Skip to content

BIOGNOST

Active
Private limited companyfounded 199530 yrs activeWaterven(Heu) 11, 8501 Kortrijk, BelgiumKBO/BCE: BE 0456.661.548
Summary

BIOGNOST has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.8m and a net result of €3.6m. Equity is growing by ~40.5% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisWatch ReportCompare
BIOGNOSTActiveChecked score 76/100
Risk analysis ReportCompare

Overview

What they do
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
How big
€7.0mtotal assets 2024
Staff
10.4 FTE
Equity
€1.8m
Profit
€3.6m
Turnover not published (abridged schema)
Financially healthy?
76 Excellent Checked score 2024
Bankruptcy chance 12 m
0.4%
Who decides
Parent
BIOGNOST FILIA · 70%
Holdings
1
Accounts 37 d early0 of 8 deeds read
Why 76- Higher-failure-rate sector+ Long track record+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence

Checked score

Score 2024
76 / 100
Excellent
Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency51▲+1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €130,000 at 30 days acceptable
Liquidity tight (current ratio 1.28 against 1.28 in 2023; short-term debt: 68.6% and cash: 50.2% of total assets), and 73.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 30 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
26.3%
Return on assets
51.6%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-06-2026, 37 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
37 d early
2024
38 d early
2023
40 d early
2022
56 d early
2021
37 d late
2020
38 d early
2019
18 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 27 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 23 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · abbreviated…
  3. Annual accounts filedfiscal year 2023 · abbreviated…

Key points

  • Controlled by BIOGNOST FILIAknown shareholders 100% 70% View
  • Positive: 7 profitable years in a rowprofit 2024: €3.6m 7 years View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

By topic

Financials

Fiscal year
2024
Total assets
€7.0m
Profit
€3.6m
Solvency
26.3%
Go to Financials

Timeline

Events
13
Since
2017
Next accounts
by 31-07-2027
  1. 24-06-2026Annual accounts filed
  2. 23-06-2025Annual accounts filed
  3. 21-06-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
20-12-1995
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure